442 related articles for article (PubMed ID: 20869431)
1. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.
Chang L; Chen Y; Li J; Liu Z; Wang Z; Chen J; Cao W; Xu Y
Brain Behav Immun; 2011 Feb; 25(2):260-9. PubMed ID: 20869431
[TBL] [Abstract][Full Text] [Related]
2. CART protects brain from damage through ERK activation in ischemic stroke.
Jia J; Chen X; Zhu W; Luo Y; Hua Z; Xu Y
Neuropeptides; 2008; 42(5-6):653-61. PubMed ID: 18644622
[TBL] [Abstract][Full Text] [Related]
3. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
4. Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke.
Niu FN; Zhang X; Hu XM; Chen J; Chang LL; Li JW; Liu Z; Cao W; Xu Y
Brain Behav Immun; 2012 Jan; 26(1):61-71. PubMed ID: 21802508
[TBL] [Abstract][Full Text] [Related]
5. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
Royl G; Balkaya M; Lehmann S; Lehnardt S; Stohlmann K; Lindauer U; Endres M; Dirnagl U; Meisel A
Brain Res; 2009 Apr; 1265():148-57. PubMed ID: 19368809
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
7. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
[TBL] [Abstract][Full Text] [Related]
8. Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats.
Allahtavakoli M; Jarrott B
Brain Res Bull; 2011 May; 85(3-4):219-24. PubMed ID: 21453760
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
10. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
12. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
13. Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Poittevin M; Deroide N; Azibani F; Delcayre C; Giannesini C; Levy BI; Pocard M; Kubis N
J Neuroimmunol; 2013 Jan; 254(1-2):55-62. PubMed ID: 23026222
[TBL] [Abstract][Full Text] [Related]
14. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice.
Zhu W; Dotson AL; Libal NL; Lapato AS; Bodhankar S; Offner H; Alkayed NJ
Neuroscience; 2015 Mar; 288():112-9. PubMed ID: 25556831
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke.
Shabanzadeh AP; Shuaib A; Wang CX
Brain Res; 2005 Apr; 1042(1):1-5. PubMed ID: 15823246
[TBL] [Abstract][Full Text] [Related]
16. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
[TBL] [Abstract][Full Text] [Related]
17. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.
Hurn PD; Subramanian S; Parker SM; Afentoulis ME; Kaler LJ; Vandenbark AA; Offner H
J Cereb Blood Flow Metab; 2007 Nov; 27(11):1798-805. PubMed ID: 17392692
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the cocaine-amphetamine regulated transcript peptide (CART 55-102) in the modulation of rat immune cell activity.
Bik W; Skwarlo-Sonta K; Szelagiewicz J; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska-Bik A; Baranowska B
Neuro Endocrinol Lett; 2008 Jun; 29(3):359-65. PubMed ID: 18580846
[TBL] [Abstract][Full Text] [Related]
20. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.
Sevimli S; Diederich K; Strecker JK; Schilling M; Klocke R; Nikol S; Kirsch F; Schneider A; Schäbitz WR
Exp Neurol; 2009 Jun; 217(2):328-35. PubMed ID: 19332060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
